Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03438760 · ClinicalTrials.gov registry record · NA
Improving STEM Outcomes for Young Children With Language Learning Disabilities
A NA study, sponsored by Father Flanagan's Boys' Home.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT03438760: Clinical Trial NA study, sponsored by Father Flanagan's Boys' Home.
NCT03438760 is a NA study that was terminated before completion, run by Father Flanagan's Boys' Home. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03438760, a NA study, was terminated before completion, sponsored by Father Flanagan's Boys' Home.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). The purpose of this randomized controlled trial is to test vocabulary and grammar interventions embedded in a small-group inquiry-based science instruction for their potential to ameliorate language deficits that impede science learning. Participants will be 54 preschoolers or kindergartners with SLI. Proximal and distal probes will reveal their mastery of taught and generalized language and science concepts.
Primary Outcome
The outcome relevant to aim 1 will be measured with eight 10-item, proximal concept assessments (to cover content taught during the intervention period) and two 10-item proximal assessments (to cover content taught after the intervention has been withdrawn). These will all be administered during the withdrawal week. These will be adapted from the FOSS I-check probes (e.g., Item 1: What is in the night sky? Stars? Sun? Moon?). From these, an accuracy score will result. The investigators will be a
Interventions
- BEHAVIORAL Science + Phonological Awareness
- BEHAVIORAL Science + Grammar Intervention
- BEHAVIORAL Science + Vocabulary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-11-03 |
| Est. Completion | 2020-08-30 |
| Phase | NA |
Why NCT03438760 stopped before completion
NCT03438760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Science + Phonological Awareness is the first listed.
NCT03438760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03438760 about?
NCT03438760 is a clinical study titled "Improving STEM Outcomes for Young Children With Language Learning Disabilities". The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). The purpose of this randomized controlled trial is to test vocabulary and grammar interventions embedded in a sma...
What is the current status of trial NCT03438760?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2017-11-03. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT03438760?
The interventions under investigation include: Science + Phonological Awareness (BEHAVIORAL), Science + Grammar Intervention (BEHAVIORAL), Science + Vocabulary Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03438760?
This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03438760's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI